2m 2m 2m 2m 2m 2m 2m
Gilead Sciences (GILD)
NASDAQ
$144.62-$2.88 (-1.95%)
Price as of Oct 02, 2026 3:23 PM EDT- $182.9BMarket Cap
- 36.71%1-Year Change
- Drug Manufacturers - GeneralIndustry
Gilead Sciences (GILD)
$144.62-$2.88 (-1.95%)
GILD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $147.50 | ||
Change | -$1.55 (-1.04%) | ||
Open | $149.44 | ||
High | $149.44 | ||
Low | $147.19 | ||
Previous Close | $149.05 | ||
Volume | 4,438,697 | ||
30-Day Average Volume | 5,809,993 | ||
1-Week Change | -1.46% | ||
1-Month Change | -1.06% | ||
1-Year Change | 36.71% | ||
3-Year Change | 116.34% | ||
5-Year Change | 157.08% | ||
Fundamentals | |||
Shares Outstanding | 1.2B | ||
Total Assets | $49.4B | ||
Market Cap | $182.9B | ||
Enterprise Value | $206.0B | ||
Period: QTR TTM FY | |||
Revenue | $7.6B | ||
Net Income | -$10.5B | ||
Free Cash Flow | $3.4B | ||
EBIT | -$10.3B | ||
EBITDA | -$10.2B | ||
Net Working Capital | $2.9B | ||
EPS | -$8.45 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 27 | ||
P/B | 15 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | 53 | ||
Price/Operating Cash Flow | 51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.22% | ||
Trailing Annual Dividend Yield | 2.20% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/28/2013 | ||
Earnings & Revenue
Annual Dividend Yield